Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by 12gaugeRAGEon Jan 15, 2018 4:23pm
156 Views
Post# 27362455

RE:Thoughts on a buyout?

RE:Thoughts on a buyout?I don't see LIB being bought out. They would be very appealing to the major players, but I believe LIB is more than happy doing this on their own. With the direction(s) they are taking, they're not a flash in the pan. Cultivation, distribution, and a very underestimated value in ESEV pet products... well on their way to being a great success story. North Road vault capacity currently at $6.25m with plans to expand to $32m(verify?) in the future once DL is acquired. Just Kush facility is currently smaller than we'd like, but won't stay that way for long. Pet care CBD market is also estimated to be a multi-billion $ market. Some of my holdings in the sector are simply until licensing. Others are longer holds. LIB and LG are my longs (2019 and beyond) while MYM has already been 10x+, just waiting on license news to cash out 25%. Large position in MMJ since .145 which I plan to liquidate 75% after license. Waiting for some news from CANN before I decide how long to stick around there... likely a buyout coming from Canopy there since they are already partnered to an extent. MPX I doubled and sold, but will be back in after a few of these other licenses roll in. MMJ and CANN expecting Feb licenses. MPX not expecting HC license until summer (although they currently have very good revenue from US dispensaries). 
  The skinny... Lots of companies will want to be involved with LIB once licenses come in. But I don't expect anything substantial to happen in terms of buyout talks until the DL license is official. And by then my .16/.18 shares will be 10x. Congrats to those who didn't panic and sell off during the plunge last week. Hold strong, this one's a winner all day long! Cheers
<< Previous
Bullboard Posts
Next >>